SCHEMBL7416388

SCHEMBL7416388

Cc1ccc(C=CCC2CCCCN2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.38
KDM4E B2RXH2 1/20 0.36
HTR1A P08908 1/20 0.35
HTR1D P28221 1/20 0.35
HTR2A P28223 1/20 0.35
HRH1 P35367 1/20 0.35
ADRA1B P35368 1/20 0.35
KCNH2 Q12809 1/20 0.35
LTA4H P09960 5/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416385 1.00 POLB (0.41) POLBTRPM8KDM4EHTR1AHTR1D
SCHEMBL7406775 0.85 LTA4H (0.49) POLBHTR1AHTR1DHTR2AHRH1
SCHEMBL7419865 0.85 LTA4H (0.49) POLBHTR1AHTR1DHTR2AHRH1
SCHEMBL7407987 0.85 LTA4H (0.49) POLBHTR1AHTR1DHTR2AHRH1
SCHEMBL7407991 0.85 LTA4H (0.49) POLBHTR1AHTR1DHTR2AHRH1
SCHEMBL7406773 0.85 LTA4H (0.49) POLBHTR1AHTR1DHTR2AHRH1
SCHEMBL7407929 0.84 POLB (0.54) POLBKDM4EHTR1AHTR1DHTR2A
SCHEMBL7406856 0.84 POLB (0.54) POLBKDM4EHTR1AHTR1DHTR2A
SCHEMBL7418424 0.84 POLB (0.54) POLBKDM4EHTR1AHTR1DHTR2A
SCHEMBL7410677 0.84 SLC6A2 (0.46) TRPM8KDM4ELTA4HALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734379-B1 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF PARKE DAVIS (FR) 2001-03-07 EP disclosed
EP-0995436-A2 Ligands for sigma receptors and their therapeutical applications PARKE-DAVIS (FR) 2000-04-26 EP disclosed
US-6013656-A PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-01-11 US disclosed
US-5849760-A 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors INSTITUT DE RECHERCHE JOUVEINAL (FR) 1998-12-15 US disclosed
EP-0734379-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (I.R.J) (FR) 1996-10-02 EP disclosed
WO-1995015948-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (FR) 1995-06-15 WO disclosed